Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia

Menée à l'aide de modèle murins et de xénogreffes, cette étude met en évidence des mécanismes par lesquels le gène Gfi1 favorise le développement d'une leucémie lymphoblastique aiguë

Résumé en anglais

Most patients with acute lymphoblastic leukemia (ALL) fail current treatments highlighting the need for better therapies. Because oncogenic signaling activates a p53-dependent DNA damage response and apoptosis, leukemic cells must devise appropriate countermeasures. We show here that growth factor independence 1 (Gfi1) can serve such a function because Gfi1 ablation exacerbates p53 responses and lowers the threshold for p53-induced cell death. Specifically, Gfi1 restricts p53 activity and expression of proapoptotic p53 targets such as Bax, Noxa (Pmaip1), and Puma (Bbc3). Subsequently, Gfi1 ablation cures mice from leukemia and limits the expansion of primary human T-ALL xenografts in mice. This suggests that targeting Gfi1 could improve the prognosis of patients with T-ALL or other lymphoid leukemias.

º High Gfi1 expression is associated with a subgroup of T-ALL
º Gfi1 is required for the development and maintenance of both T and B cell tumors
º Lymphoid tumors need Gfi1 to counteract DNA damage-induced, p53-mediated apoptosis
º Inhibiting GFI1 impedes the expansion of primary human T-ALL in xenograft model